1.19
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
1.7607
|
- | 2.3398 | 3.2003 | 3.2257 |
| Operating Income/Loss |
-1.7607
|
- | -2.3398 | -3.2003 | -3.2257 |
| Income/Loss From Continuing Operations Before Tax |
0.54%
-1.692
|
-1.7011 | -2.3036 | -3.1509 | -3.1732 |
| Income/Loss From Continuing Operations After Tax |
0.54%
-1.692
|
-1.7011 | -2.3036 | -3.1509 | -3.1732 |
|
|
0.54%
-1.692
|
-1.7011 | -2.3036 | -3.1509 | -3.1732 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.0265
|
- | 5.1547 | - | - |
| Diluted Average Shares |
1.0265
|
- | 5.1547 | - | - |
| Basic Earnings Per Share |
-1.65
|
- | -0.45 | - | - |
| Diluted Earnings Per Share |
-1.65
|
- | -0.45 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):